CoChat

Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1α and PPARβ/δ gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus

Open access
Mensink, M, Hesselink, M K C, Russell, A P, Schaart, G, Sels, J-P, Schrauwen, P · 2007 · International Journal of Obesity

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

Objective To examine whether rosiglitazone alters gene expression of some key genes involved in mitochondrial biogenesis and oxidative capacity in skeletal muscle of type 2 diabetic patients, and whether this is associated with alterations in skeletal muscle oxidative capacity and lipid content.Design measured in muscle biopsies obtained from diabetic patients, before and after 8 weeks of rosiglitazone treatment, and matched controls. Furthermore, whole-body insulin sensitivity and substrate utilization were assessed.Subjects Ten obese type 2 diabetic patients and 10 obese normoglycemic controls matched for age and BMI.Methods Gene expression and mitochondrial protein content of complexes I-V of the respiratory chain were measured by quantitative polymerase chain reaction and Western blotting, respectively. Histochemical staining was used to quantify lipid accumulation and complex II succinate dehydrogenase (SDH) activity. Insulin sensitivity and substrate utilization were measured during a hyperinsulinemic-euglycemic clamp with indirect calorimetry.Results Skeletal-muscle mRNA of PGC-1 alpha and PPAR beta/delta--but not of other genes involved in glucose, fat and oxidative metabolism--was significantly lower in diabetic patients (P<0.01). Rosiglitazone significantly increased PGC-1 alpha ( approximately 2.2-fold, P<0.01) and PPAR beta/delta ( approximately 2.6-fold, P<0.01), in parallel with an increase in insulin sensitivity, SDH activity and metabolic flexibility (P<0.01). Surprisingly, none of the measured mitochondrial proteins was reduced in type 2 diabetic patients, nor affected by rosiglitazone treatment. No alterations were seen in muscular fat accumulation upon treatment.Conclusion These results suggest that the insulin-sensitizing effect of rosiglitazone may involve an effect on muscular oxidative capacity, via PGC-1 alpha and PPAR beta/delta, independent of mitochondrial protein content and/or changes in intramyocellular lipid.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.ijo.0803567

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 26 references

Cited by

See all 180

Metadata

Authors
Mensink, M., Hesselink, M. K. C., Russell, A. P., Schaart, G., Sels, J.-P., & Schrauwen, P.
Affiliations
  • Maastricht University (NL)
  • Deakin University (AU)
  • Maastricht University Medical Centre (NL)
Corresponding author
Mensink, M
Venue
International Journal of Obesity
Published
2007-02-20
Volume
31
Issue
8
Pages
1302-1310
ISSN
  • 0307-0565 (ISSN-L)
  • 1476-5497
OpenAlex
W2114190855
Cited by
160
References
26
Citations by year
2026: 3 · 2025: 3 · 2024: 2 · 2023: 5 · 2022: 5 · 2021: 6 · 2020: 4 · 2019: 6 · 2018: 10 · 2017: 11 · 2016: 7 · 2015: 4 · 2014: 9 · 2013: 8 · 2012: 11
FWCI
6.62
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • International Journal of Obesity (publishedVersion)
  • PubMed (publishedVersion)
  • Socio-Environmental Systems Modeling (acceptedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
Koninklijke Nederlandse Akademie van Wetenschappen
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
rosiglitazone, type 2 diabetes, skeletal muscle, PGC-1α, PPARδ, mitochondrial biogenesis, oxidative capacity, insulin sensitivity, metabolic flexibility, succinate dehydrogenase, intramyocellular lipid, mitochondrial protein content, gene expression
MeSH terms
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Rosiglitazone, Biopsy, Blood Glucose, Diabetes Mellitus, Type 2, Gene Expression Regulation, Heat-Shock Proteins, Humans, Hypoglycemic Agents, Insulin Resistance, Male, Middle Aged, Mitochondria, Muscle, Obesity, Transcription Factors, Case-Control Studies, Muscle, Skeletal, Mitochondrial Proteins, Thiazolidinediones, PPAR-beta, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.